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Abstract
Background—Long term mortality may be increased following traumatic brain injury (TBI); 
however the degree to which survival could be reduced is unknown. We aimed to model life 
expectancy following post-acute TBI to provide predictions of longevity and quantify differences 
in survivorship with the general population.
Methods—A population based retrospective cohort study using data from the Rochester 
Epidemiology Project (REP) was performed. A random sample of patients from Olmsted County, 
Minnesota with a confirmed TBI between 1987 and 2000 was identified and vital status 
determined in 2013. Parametric survival modelling was then used to develop a model to predict 
life expectancy following TBI conditional on age at injury. Survivorship following TBI was also 
compared with the general population and age and gender matched non-head injured REP 
controls.
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Results—769 patients were included in complete case analyses. Median follow up time was 16.1 
years (IQR 9.0–20.4) with 120 deaths occurring in the cohort during the study period. Survival 
after acute TBI was well represented by a Gompertz distribution. Victims of TBI surviving for at 
least 6 months post-injury demonstrated a much higher ongoing mortality rate compared to the US 
general population and non-TBI controls (hazard ratio 1·47, 95% CI 1·15–1·87). US general 
population cohort life table data was used to update the Gompertz model’ s shape and scale 
parameters to account for cohort effects and allow prediction of life expectancy in contemporary 
TBI.
Conclusions—Survivors of TBI have decreased life expectancy compared to the general 
population. This may be secondary to the head injury itself or result from patient characteristics 
associated with both the propensity for TBI and increased early mortality. Post-TBI life 
expectancy estimates may be useful to guide prognosis, in public health planning, for actuarial 
applications and in the extrapolation of outcomes for TBI economic models.
Keywords
Craniocerebral trauma; Survival analysis; Mortality
INTRODUCTION
Injury is a major public health problem, predicted by the World Health Organization to 
become the 4th largest global burden of disease by 2020.[1] Traumatic brain injury (TBI) 
comprises an important subset of injury cases, but despite its importance in terms of 
mortality, morbidity and socio-economic costs important epidemiological aspects, such as 
life expectancy, remain largely undefined.[2]
There is a growing body of evidence suggesting that long-term mortality is increased 
following TBI compared to the non-head injured population. For example Ventura and 
colleagues (2010) reported a standardised mortality ratio of 2·5 (95%CI 2·3–2·7) compared 
to the general population for adult patients discharged from hospital with significant TBI.[3] 
However, no previous study has quantified the absolute extent to which length of survival 
might be reduced in a representative sample of patients following TBI, or extrapolated 
observed survival to predict future life expectancy. Such information could be beneficial in a 
number of different areas.
Firstly, longevity estimates would be of interest to patients, carers and clinicians as a guide 
to long term prognosis following in injury. Secondly, an indication of the long term burden 
of patients with chronic complications would be helpful in planning public health services 
for TBI. Thirdly, accurate life expectancy estimates are necessary for actuarial applications 
and medico-legal settlements. Finally, cost-effectiveness evaluations for TBI interventions 
need to extrapolate outcomes over a lifetime horizon to fully reflect health effects and 
prevent bias.[4] It is therefore imperative that valid estimates of long term survival specific 
to victims of TBI are available.
The aim of this study was to increase understanding of survival following acute TBI and 
provide extrapolative estimates of life expectancy. Specific objectives were to develop 
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parametric statistical models to accurately reflect survival after TBI and allow extrapolation 
for prediction of life expectancy, and estimate the relative difference in hazard of death 
between patients with TBI and the general population.
METHODS
Study design
A population based cohort study was performed, retrospectively analysing data from the 
Rochester Epidemiology Project (REP); a comprehensive demographic and medical records-
linkage system for all residents of the Olmsted County, Minnesota, USA.[5] Survival 
following acute TBI was investigated using parametric survival analysis methodology.
Setting
Olmsted County (2010 census population, 144,248) is situated in the upper mid-west region 
of the US. The county is primarily served by the Mayo Clinic, one of the largest private 
medical practices in the world, and the Olmsted Medical Center, a community hospital with 
long-term collaborative research ties to the REP. Its population is 90% white with an age and 
sex distribution comparable with the US total population. Olmsted county residents are more 
highly educated and have higher median income than the general US population.[6] 
Mortality rates are consistent with the wider Minnesota population, but slightly lower than 
those from the total national population.[6]
Since 1907 every Mayo Clinic patient has been assigned a unique identifier, used to record 
and link medical information from all health care providers in any setting within Olmsted 
County, including nursing home, primary, secondary or tertiary healthcare.[5] From 1966 the 
REP has maintained an electronic database recording diagnostic codes, surgical procedure 
codes and demographic information abstracted from medical records and assigned at every 
medical contact. The coding system is based on the International Classification of Diseases 
system (ICD-8 and ICD-9), uses an 8 digit number, and was developed specifically for 
clinical and research purposes. Additionally, all medical records are archived in a single, 
unified, continuously updated file; historically in paper form but more recently in searchable 
electronic format. The REP therefore represents an essentially complete record of the entire 
health experience within the geographically defined population of Olmsted County, 
regardless of age, socioeconomic status, or insurance coverage.[7] Furthermore, the REP 
database additionally provides an ongoing census of individuals as they move in and out of 
the community, recording address changes at each medical attendance.[8]
Study population
The source population comprised Olmsted County residents with any code suggestive of 
TBI in the REP diagnostic index from 1/1/1985 to 31/12/1999. A 15% random sample, 
determined was selected for review of their complete medical records to identify a study 
population of incident TBI cases. The review was performed by trained nurse abstractors 
under the supervision of a board-certified physiatrist and neuropsychologist. TBI was 
defined as any traumatically induced injury that contributed to physiological disruption of 
brain function. The cohort thus included the entire spectrum of TBI severities from those 
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assessed in primary care to critical care admissions. The criteria used for the identification of 
TBI within clinical records are detailed in the web appendix.
Significant TBI typically results in high early mortality; as long term survival of patients 
beyond the acute period was of interest, cases dying within 6 months of injury were 
excluded. This 6 month time period is the most established endpoint to evaluate acute 
outcomes in clinical TBI studies.[9] Full information on ED and hospital admissions was 
first available electronically from 1987 and cases were consequently restricted to those 
presenting after this date. The final sample therefore consisted of adult patients sustaining a 
confirmed TBI between 1/1/1987 to 31/12/1999 aged >16 years, who survived beyond 6 
months and consented to data use.
To provide a comparison population for judging the external validity of TBI parametric 
models, non-TBI controls were also examined. In these analyses each TBI case was matched 
to an Olmsted County resident of the same gender and similar birth year (within one year), 
but who did not have a REP diagnostic code potentially suggestive of TBI. This matched 
sample was judged likely to have similar characteristics to those sustaining TBI, thus 
providing a survival experience against which the predicted survival following TBI could be 
evaluated.
Data collection
Demographic and injury information was abstracted from each patient’ s clinical records by 
trained research nurses and entered into an electronic database. Vital status was determined 
on the 31st September 2013 by review of REP medical records, Olmsted County obituary 
notices, local death certificates, and State of Minnesota death tapes. Persons for whom death 
was not recorded were considered censored as of the date they were last known to be 
Olmsted County residents.
Statistical analyses
The cohort’ s characteristics were initially examined using descriptive statistics. Observed 
survival experience was then examined using the Kaplan-Meier product limit method to 
compare empirical cumulative incidence functions categorised by age-group at TBI and 
other patient variables. Log-rank tests were used to test the null hypothesis that survival 
curves did not differ across categories of dichotomous variables; and log-rank test for trend 
used to test ordinal variables.
Parametric survival modelling then proceeded in four stages.[10,11] Firstly the plausibility 
of alternative parametric functions from the generalised F distribution for describing survival 
time after TBI was evaluated. Graphical analyses were performed to assess survival time 
distribution, proportional hazards or accelerated failure time assumptions. To account for the 
fact that standard parametric models might not accurately reflect the true hazard function 
associated with TBI, flexible modelling of the baseline hazard with cubic splines was 
additionally assessed.
Secondly, potentially suitable parametric survival models were applied to the data. Age at 
head injury alone was examined in the primary model, with age at head injury, gender and 
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other patient characteristics (including TBI severity, comorbidity and hospitalisation) 
considered as explanatory variables in separate secondary models. Goodness of fit metrics 
were assessed, using Akaike’ s Information Criterion (AIC), the Bayesian Information 
Criterion (BIC), mean squared differences in observed and predicted survival, and a 
comparison of predicted survival functions against observed Kaplan-Meier curves, to select 
the model(s) that best fitted REP data. AIC and BIC provide a numerical measure of both 
how well a model fits the data and how complex the model is, and can therefore be used to 
identify the most favourable model from a range of possibilities. Mean squared differences 
in observed and predicted survival (lower is better numerical value is better), and a 
comparison of predicted against observed survival functions (closer visual fit is better), offer 
a direct evaluation of well a model mirrors the actual data.
Thirdly the external validity of the chosen models was assessed by evaluating the 
concordance of predicted survival against published estimates, and regional and national 
general population life tables. Extrapolated survival curves were also compared with those 
of age-matched non-TBI controls sampled from the REP. Final model selection was 
determined by the best statistical fit to REP data whilst providing credible long term survival 
predictions.
The final model provides survival and hazard curves based on the survivorship experience of 
patients who had a head injury between 1988 and 1999. Since that time there has been a 
secular trend of improving life expectancy in the general US population and the model may 
therefore slightly underestimate survival of contemporary TBI cases. The shape and scale of 
the model’ s baseline hazard function were therefore updated in the final analysis stage, 
based on temporal changes in survival curves observed in the US general population.
The indicated parametric distribution was fitted to the adult age-range (>16 years) of 
published US cohort life tables between 1930 and 2010 (the last available publication) using 
least squares non-linear regression. The proportional change in shape and scale parameters 
over time from 2000 were then determined by non-linear regression and the parameters of 
the baseline hazard function of the final derived REP model updated accordingly.[12]
Statistical analyses were carried out in Stata version 12·1 (StataCorp, College Station, USA). 
A two-sided p-value of <0.05 was considered to be statistically significant. Thorough model 
diagnostics were performed to ensure correct specification and validity at each step of the 
modelling procedure. Full details on statistical analyses, including scenario sensitivity 
analyses to investigate the potential influence of non-informative censoring, are presented in 
the web appendix. All analyses were pre-specified in a study protocol submitted to the Mayo 
Clinic institutional review board. Ethical approval was provided by the Mayo Clinic and 
Olmsted Medical Centre institutional review boards. Patient consent for use of personal data 
was obtained in accordance with Minnesota and Federal law.
Role of the funding source
The study was sponsored and funded by the Mayo Clinic. All authors had full access to the 
data in the study and had final responsibility for the decision to submit for publication.
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RESULTS
Sample characteristics
46,114 unique Olmsted County residents were assigned a diagnostic code potentially 
indicative of TBI between 1985 and 1999. 323 patients were excluded who refused 
authorisation to disclose personal information for research. The medical records of a random 
sample of 7,175 cases (15%) were examined in detail, confirming 1,429 incident cases of 
TBI with 1,257 injured after 01/01/1987. Of these 769 patients were aged >16 years at 
injury, survived at least 6 months post injury and were included in complete case analyses. 
There was missing data on patient ethnicity in 21·7% of cases (161 unknown, 6 refused 
disclosure) and TBI mechanism in 0·4% of patients. All other patient characteristics had 
complete information. Figure 1 presents the derivation of the final study sample.
Median follow up time was 16.1 years (IQR 9·0–20·4) with 120 deaths occurring during the 
study period. Four hundred and forty six patients (58.0%) were administratively right 
censored at the end of follow up in September 2013 (median follow up=19.3 years IQR 
16·4–22·2). Two hundred and three (26·4%) cases left Olmsted County prior to the end of 
the study and were non-administratively censored (median follow time 4.9 years IQR 1·4–
10·2). The reverse Kaplan-Meier estimate of overall median follow up was 17.3 years 
(95%CI 16·6–18·0). The completeness index (ratio of total observed to potential person-time 
of follow up) was 77·7%.
The median age of the study sample was 30·3 years (Inter-quartile range 21·5–43·7) with 
males accounting for 50·2% of cases (95% confidence interval (CI) 46·7–53·7%). White 
ethnicity dominated, representing 92·9% (95%CI 90·8–94·9) of enrolled patients. The 
commonest modes of injury were road accidents (43·7%), falls (24·7%), sports-related 
trauma (9·2%) and assaults (7·8%). A significant minority of patients presented with a 
concomitant extra-cranial injury (23·3%, 95% CI 20·3–26·3%). Mild head injury 
preponderated and was responsible for 93·2% (95% CI 91·5–95·0%) of included cases. 
Patient characteristics are summarised in table 1.
Empirical cumulative incidence curves for the REP TBI population calculated using the 
Kaplan-Meier method and categorised by age at first TBI are shown in Figure 2. A log rank 
test for trend indicated significantly decreased survival as age group at first TBI increased: 
(young adult (16–39 years); middle aged (40–64 years); elderly (>65 years) subgroups, 
p<0·001). No significant difference in empirical survivor function was evident in crude 
analyses examining the presence of extra-cranial injury, gender and ethnicity (log rank tests, 
p=0·34–0·43). However, there was some evidence of increased mortality rates associated 
with male gender after adjustment for age at TBI (stratified log rank test, p=0·08). Of note, a 
significant difference in survival was apparent between patients with mild and moderate/
severe TBI in univariate analysis (log rank test p<0.01). However the effect of TBI severity 
was lost after adjustment for age (with or without gender, stratified log rank test, p=0.53–
0.55). Survival curves categorised by gender, TBI severity and other patient characteristics, 
are presented in the web appendix.
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Parametric survival analysis
Primary model development—The primary analysis modelled the effect of age at first 
TBI on long-term survival. The Weibull model and Gompertz distributions were identified as 
potential candidate models based on linear log cumulative hazard plots and approximately 
linear smoothed log-hazard plots respectively. Proportionality of hazards with increasing age 
at TBI was confirmed graphically using log cumulative hazard, log hazard and kernel 
smoothed hazard plots. For both Gompertz and Weibull models age at TBI demonstrated an 
approximately quadratic relationship with log-hazard and was modelled using a first degree 
fractional polynomial of power 2. There was no evidence of change in distribution shape 
with increasing age, unexplained heterogeneity, or time-varying age coefficients.
A Gompertz model demonstrated the best fit to the REP data with lower information 
criterion statistics (AIC 529·7 v 531·9, BIC 543·6 v 545·8) and lower sum of squared errors 
(1,074 v 32,335) compared to the Weibull model. Survival curves from this model 
demonstrated satisfactory fit to the observed Kaplan-Meier curves for each age group, with 
almost all predicted survival probabilities (calculated for the median age of each age 
category) remaining within the 95% confidence interval bounds as demonstrated in Figure 3. 
All model diagnostics were unremarkable, with no evidence for any model misspecification, 
as detailed in the web appendix.
Extrapolated TBI survival curves from the Gompertz model demonstrated lower relative 
survival compared with those derived from US general population cohort life tables from the 
year 2000. TBI patients also demonstrated decreased survival when compared to age and 
gender matched non-TBI REP controls in a Gompertz proportional hazards model (hazard 
ratio 1·47, 95% CI 1·15–1·87). Predicted median survival following a TBI at the ages of 25, 
52 and 79 years were 45·8 years (95%CI 38·0–53·6), 30.6 years (95%CI 26·8–34·5) and 9·0 
years (95%CI 7·8–10·3) respectively; compared to 53.5 (95%CI 40·7–66·4), 36·7 (95%CI 
29·7–43·7) and 11.5 (10·0–13·0) for non-TBI controls.
The Gompertz TBI survival curves demonstrated plausible extrapolation of long term 
survival, based on theoretical considerations, comparisons with general population survival 
patterns, and correlation with published survival estimates following TBI. Gompertz 
distributions are well known to accurately represent long term survival in general adult 
populations and therefore has face validity based on a priori reasoning. Illustrative 
extrapolated survival functions for TBI patients at 25, 52 and 79 years of age were 
indistinguishable in pattern (showing a lower relative survival for patients following TBI) 
compared to age and gender matched non-TBI REP controls, Minnesota general population 
period life tables from the same period, and corresponding year 2000 US general population 
cohort survival curves (Figure 4). Median survival times reported in the current study were 
also not discordant with previously estimates reported by Ventura 2010, Felix-Harrison 2009 
and 2004, and Strauss 1998. Full details of an evaluation of the model’ s external validity are 
presented in the web appendix.
Model updating—Survival curves derived from US general population cohort life tables 
demonstrated increasing ‘ rectangularisation’  and rightward shift between 1930 and 2010. 
Gompertz distributions showed an excellent fit to the corresponding hazard functions with 
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high adjusted R2 (0.99) and good visual fit of observed and fitted values. The shape and log 
scale parameters of these Gompertz distributions displayed a shallow concave relationship 
with time, best fitted by a quadratic function when using non-linear regression. Model fit 
was satisfactory with excellent visual concordance between fitted and observed values, high 
adjusted R2 (>0·999) and low sum of mean squared errors (0·0004 and 0·0003 for shape and 
log-scale parameters respectively). Full details on the modelling of secular trends in US 
general population survivorship, and the final updated Gompertz model for predicting long 
term survival after TBI, are described in the web appendix.
Additional analyses—Details of a secondary model including gender as an explanatory 
variable to predict survival, and the results of sensitivity analyses investigating non-
informative censoring, are shown in the web appendix.
DISCUSSION
Summary of results
Survival after acute TBI followed a Gompertz distribution, with increasing age at head 
injury having an approximately quadratic relationship with the log-hazard of dying. Victims 
of TBI, surviving for at least 6 months post-injury, demonstrated a much higher ongoing 
mortality rate compared to non-TBI controls and the US general population. Gompertz 
distributions fitted to US general population cohort life tables manifested progressively 
increasing shape, and more negative log-scale parameters, between 1930 and 2010 allowing 
adjustments to the survival model to enable the prediction of survival in contemporary TBI 
patients.
Strengths and limitations
This study has a number of strengths. We studied a fully population based sample including 
the full spectrum of TBI severity and report one of the longest follow up periods of any 
published TBI cohort; providing a unique opportunity to describe survival after TBI and 
allow extrapolative estimates of life expectancy. Moreover, REP coding and data collection 
has demonstrated very high accuracy and reliability which should ensure that no incident 
cases of TBI have been missed.[5] Furthermore, the REP census enumeration has been 
validated, demonstrating excellent concordance with decennial US censuses and random-
digit dialling surveys.[8] Finally, the parametric survival analysis methodology fully 
conformed to state of the art modelling recommendations.[10,11]
Conversely, there are several potential sources of systematic error, which could challenge the 
internal validity of results. Firstly, the analyses are predicated on non-informative censoring. 
However, it may be possible that patients leaving Olmsted County, with consequently short 
non-administrative censoring times, have a different prognosis to those who remained until 
to the end of the study. Reassuringly, such patients had very similar observed characteristics 
to remaining patients and sensitivity analyses simulating alternative assumptions for the 
distribution of survival times in patients lost to follow up demonstrate that the results were 
not susceptible to major change in plausible scenarios for censoring mechanisms (see web 
appendix).
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Secondly, selection bias could also have arisen during the retrospective record review, with 
inclusion of non-TBI patients and consequent overestimation of survival. Cases who 
presented only with post concussive symptoms were eligible for enrolment and it is possible 
that non-specific symptoms were incorrectly attributed to trivial recent head trauma. The 
number of patients excluded for non-participation in the REP was negligible (<0.7%) and is 
unlikely to have influenced results.
Thirdly, study participants were included over a staggered 13 year accrual period and the 
reported results assume conditional survival probabilities are the same for subjects enrolled 
early and late in the study. Small cohort effects with increased longevity, arising from 
treatment differences or demographic trends, are likely in later birth cohorts within the 
recruited sample and could result in slightly underestimated survival in the final updated 
extrapolation model.
Lastly, although the REP sample size is not dissimilar to previously reported TBI cohorts, 
there were limited numbers in some subgroups, particularly non-mild TBI patients. This 
may have prevented detection of small, but clinically significant, differences in survival 
across TBI severities, decreased the power to observe important interactions between 
explanatory variables, or reduced the precision of model predictions.
Comparison to previous studies
A number of previous studies have investigated the long term survival of patients following 
TBI compared with the general population or non-head injury controls.[3,13–21] The 
finding of higher long term mortality following TBI has been consistently observed in a 
range of different settings (Europe, North America, Australasia), varying TBI populations 
(hospitalised, outpatient, and rehabilitation samples), contrasting study designs (population 
and non-population based studies, matched or un-matched samples), and alternative effect 
estimates (standardised mortality ratios, risk ratios, and odds ratios). Our results are 
concordant with these studies, but the novel use of parametric survival analysis, computing a 
hazard ratio between TBI and non-TBI patients, comparing TBI survival projections with 
general population life tables, and predicting post-TBI life expectancy are additional unique 
contributions to knowledge in this field.
Previous investigations have primarily had an epidemiological focus on whether TBI is an 
independent risk factor for premature death per se, often reporting effect estimates adjusted 
for multiple confounders. This approach has limited relevance to the prediction of post-acute 
mortality where crude estimates of absolute longevity are required conditional on certain 
demographic characteristics. A small number of studies have attempted to predict post-TBI 
life expectancy, projecting survival by adjusting abridged period life tables with age-specific 
mortality risks. This approach gives very coarse survival functions and is critically limited 
by the improbable assumption that contemporary cross-sectional mortality rates will 
continue for the lifespan of a subject, thus substantially underestimating longevity.
Interpretation of findings
To be relevant for the prediction of post-TBI life expectancy, the temporal and geographical 
generalisability of the final survival model requires close scrutiny. The external validity of 
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the REP population has been studied in detail and the current findings are likely to be 
applicable to the upper mid-west and US white population.[6] Furthermore, Minnesota life 
expectancies are congruent with many Northern and Western European countries further 
increasing the applicability of results. Conversely, the proportion of female patients 
sustaining TBI was relatively high in the REP sample and the primary model, unadjusted for 
gender, may therefore be unrepresentative of other mixed head injury populations.
Model predictions are based on a historical population, possibly reflecting bygone survival 
experiences. The use of external data in clinical prediction models is well established and 
updating shape and scale parameters to reflect modern mortality rates should increase 
external validity.[22] However, the adjusted estimates are based on the unverifiable 
assumptions that future general population survivorship will continue to follow a Gompertz 
distribution with increasing shape and more negative log-scale parameters; and that secular 
trends in patients with TBI will mirror those in the general population. Additionally, recent 
cohort life tables, used to investigate secular trends in longevity, will be largely reliant on 
projected, rather than observed, survival at older ages.
The underlying reasons for the observed increase in long term mortality rates following TBI 
compared to the general population have not been fully delineated. Cognitive and emotional 
changes are common after TBI and could lead to behavioural and social problems, such as 
substance misuse or other risk-taking actions, associated with premature death.[23,24] 
However, epidemiological evidence to support this hypothesis is limited. It is also possible 
that head injury may directly lead to life-shortening medical and psychiatric disorders. 
Recent systematic reviews and population based cohort studies have concluded that TBI of 
any severity may predispose to Parkinson’ s disease and epilepsy;[25,26] and severe TBI is 
associated with an increased risk of dementia.[27] Moreover, there is also a high incidence 
of psychiatric conditions, including schizophrenia, depression and bipolar disorders 
compared to the general population,[28] although whether this represents causation or 
association remains contentious.
Alternatively, the observed increase in mortality could be confounded by patient 
characteristics associated with both the propensity for TBI and increased early mortality. 
Patients with TBI are often young, low socio-economic status, male adults who may indulge 
in hazardous and unhealthy behaviours leading to lower life expectancy.[29] Likewise, co-
morbidities, including degenerative and non-neurological disorders, are risk factors for 
sustaining TBI in the elderly.[2] The observed increase in premature mortality could 
therefore be independent of the TBI itself, but instead be dependent on the latent health 
behaviours and medical problems typical in victims of TBI. The finding in this REP cohort 
by Brown and colleagues (2013) that there was no significant difference in the risk of death 
between patients with TBI who survived 6 months, and controls who sustained non-head 
injuries, and likely to share similar pre-morbid characteristics, supports this position.[30] 
Our finding of a lack of association between TBI severity and life expectancy in patients 
surviving the acute insult, consistent with previous literature,[30,31] further corroborates this 
position.
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Conclusions
Regardless of the aetiology, the clear finding of decreased life expectancy in patients 
surviving TBI has implications for clinical practice, public health, and health economic 
evaluations. Patients and families will be interested in the long term prognosis following 
their injuries. Knowledge of premature mortality, in conjunction with other reported findings 
of increased risk of substance misuse and suicide, may also highlight areas for preventative 
community interventions. Furthermore, these results do not support the common practice of 
using general population survivorship to extrapolate outcomes in TBI economic models.
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Figure 1. 
Flow chart delineating the derivation of the study sample.
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Figure 2. Cumulative incidence of death categorised by age-group
Shading indicates 95% confidence intervals. Vertical tick marks represent censored 
observations. The numbers at risk of death for each age group are shown in the table for 
every 5 years since TBI and the number of deaths within each interval is shown in 
parentheses
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Figure 3. Gompertz model predicted survival probabilities compared to the observed Kaplan-
Meier curves over the study period
Lines represent the Kaplan-Meier derived survival function for young, middle aged and 
elderly age groups. 95% confidence intervals for this empirical survivor function are shaded 
in grey. Symbols present the predicted survivor function from the Gompertz model for the 
median age of patients within each age group (25, 52 and 79 years respectively).
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Figure 4. Comparison of predicted extrapolative estimates of survival following TBI sustained at 
certain ages using a Gompertz distribution compared to the year 2000 US general population 
cohort life table
Black lines present the survival curves estimated from the Gompertz model following TBI 
sustained at illustrative ages. Grey lines indicate the corresponding US general population 
survival curves for patients of the same age based on cohort life table data.
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Table 1
Patient characteristics
Patient characteristic
(n=769)
Summary statistics
(%, 95%CI)
Age (Years, median, IQR) 30·3 years (21·5–43·7)
Male Gender 50·2% (46·7–53·7)
White ethnicity* 92·9% (90·8–94·9)
Extra-cranial injury 23·3% (20·3–26·3)
Mild TBI 93·2% (91·5–95·0)
Mode of injury**
 • Road accident 43·7% (40·2–47·2)
 • Fall 24·7% (21·7–27·8)
 • Sports-related 9·2% (7·2–11·3)
 • Bunt assault 7·8% (5·9–9·7)
 • Other 14·6% (12·1–17·1)
Mortality 15·6% (13·0–18·2)
*
available case analysis: n=602;
**
available case analysis n=766
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